Skip to content

Research library / Observational study

A systematic study of microdosing psychedelics

Polito V, Stevenson RJ. PLOS ONE 2019;14(2):e0211023

Observational studyOtherwellbeing

This study tracked 98 people who were already microdosing psychedelics, meaning they took very small amounts on a regular schedule. For six weeks they rated their psychological functioning every day, and 63 also completed a battery of questionnaires before and after. On dosing days people rated themselves better across all measures, but there was little sign of effects lasting into the next day. Over the six weeks, reported depression, stress and distractibility went down, while absorption and, unexpectedly, neuroticism went up. A second survey of 263 people found that expectations of microdosing were much larger and broader than the changes actual users reported. With no placebo, no check on what people took and only self-reports, the study cannot separate drug effects from expectation. The authors say controlled dosing studies are needed.

What it found

  • On dosing days, participants rated their psychological functioning higher across all measures, with little sign of carry-over to following days.
  • Over 6 weeks, reported depression, stress and distractibility fell, while absorption and neuroticism rose.
  • In the second study, people expected large, wide-ranging benefits that did not match the narrower changes actual microdosers reported.
Read the paper (free full text)

The dispatch

Laws change. Centres change. Know before you book.

A brief, sent only in weeks when something changes: jurisdictions that shifted, listings added or revised, and the research worth reading. No hype, no sourcing talk.

Educational only. Not medical advice. Unsubscribe any time.